Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Norepinephrine in Sepsis
NCT05836272Phase 4Recruiting
- Sponsor
- University of Tunis
- Start
- Aug 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of norepinephrine in sepsis (2 arms), sponsored by University of Tunis. Primary endpoint: Shock control at 6 hours. Started Aug 2023; status: recruiting.
02
Drugs
norepinephrine
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT05836272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05836272.